Synthesis and initial PET imaging of new potential dopaimine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides

被引:13
|
作者
Gao, MZ [1 ]
Mock, BH [1 ]
Hutchins, GD [1 ]
Zheng, QH [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA
关键词
(E)-4,3,2-[C-11]methoxy-N-(4-4-(2-methoxyphenyl)butyl-ci-nnamoylamides; radioligands; positron emission tomography; brain; D-3; receptors;
D O I
10.1016/j.bmc.2005.06.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-3 receptor radioligands (E)-4,3,2-[C-11]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4-[C-11]MMC, [C-11]1a; 3-[C-11]MMC, [C-11]1b; and 2-[C-11]MMC, [C-11]1c) were synthesized for evaluation as novel potential positron emission tomography (PET) imaging agents for brain D-3 receptors. The new tracers 4,3,2-[C-11]MMCs were prepared by 0-[C-11]methylation of corresponding precursors (E)-4,3,2-hydroxy-N-4-(4-(2-methoxyphenyl)piperazin-l-yl)butyl-cinnamoylamides (4,3,2-HMCs) using [C-11]methyl triflate and isolated by the solid-phase extraction (SPE) purification procedure with 40-65% radiochemical ' Ids, decay corrected to end of bombardment (EOB), and a synthesis time of 15-20 min. The PET dynamic studies of the tracers [C-11]1a-c in rats were performed using an animal PET scanner, IndyPET-11, developed in our laboratory. The results show that the brain uptake sequence was 4-[C-11]MMC > 3-[C-11]MNIC > 2-[C-11]MMC, which is consistent with their in vitro biological properties. The initial PET blocking studies of the tracers 4,3,2-[C-11]MMCs with corresponding pretreatment drugs (E)-4,3,2-methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4,3,2-MMCs, 1a-c) bad no effect on 4,3,2-[C-11]MMCs-PET rat brain imaging. These results suggest that the localization of 4,3,2-[C-11]MMCs in rat brain is mediated by nonspecific processes, and the visualization of 4,3,2-[C-11]MMCs-PET in rat brain is related to nonspecific binding. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6233 / 6243
页数:11
相关论文
共 50 条
  • [21] In Vitro and In Vivo Evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[11C]methoxybenzamide, a Positron Emission Tomography (PET) Radioligand for Dopamine D4 Receptors, in Rodents
    Leopoldo, Marcello
    Selivanova, Svetlana V.
    Mueller, Adrienne
    Lacivita, Enza
    Schetz, John A.
    Ametamey, Simon M.
    CHEMISTRY & BIODIVERSITY, 2014, 11 (09) : 1298 - 1308
  • [22] A Novel PET ligand 8-[O-methyl-11C]2-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)quinoline for 5HT1Areceptor Imaging: Synthesis, Characterization and Evaluation
    Sandhya, R.
    Varshney, R.
    Sethi, S. K.
    Ghumman, S. K.
    Mishra, A. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S420 - S420
  • [23] Synthesis, Crystal Structure and Biological Activity of N-(2-hydroxy-3-(4-(2-methoxyphenyl)-piperazin-1-yl)propyl)quinoxaline-2-methanamide
    Huang Min-Yi
    Xu Wei
    Huang Jun-Jun
    Huang Ya-Jian
    Yuan Mu
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2015, 34 (04) : 497 - 502
  • [24] Synthesis, Crystal Structure and Biological Activity of N-(2-hydroxy-3-(4-(2-methoxyphenyl)-piperazin-1-yl)propyl)quinoxaline-2-methanamide
    黄敏怡
    徐未
    黄珺珺
    黄亚建
    袁牧
    结构化学, 2015, 34 (04) : 497 - 502
  • [25] Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C]2-(4-(4-(2-methoxyphenyl) piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3, 5(2H,4H)dione in nonhuman primates
    Kumar, J. S. Dileep
    Prabhakaran, Jaya
    Majo, Vattoly J.
    Milak, Matthew S.
    Hsiung, Shu-Chi
    Tamir, Hadassah
    Simpson, Norman R.
    Van Heertum, Ronald L.
    Mann, J. John
    Parsey, Ramin V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (07) : 1050 - 1060
  • [26] Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione:: A novel agonist 5-HT1A receptor PET ligand
    Prabhakaran, J
    Parsey, RV
    Majo, VJ
    Hsiung, SC
    Milak, MS
    Tamir, H
    Simpson, NR
    Van Heertum, RL
    Mann, JJ
    Kumar, JSD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2101 - 2104
  • [27] Preparation and biodistribution of 99Tc-tricarbonyl complex with 4-[(2-methoxyphenyl)piperazin-1-yl]-dithioformate as a potential 5-HT1A receptor imaging agent
    Zhang, Xianzhong
    Zhou, Panwang
    Liu, Jiaojiao
    Huang, Yan
    Lin, Yan
    Chen, Yanlng
    Gu, Ting
    Yang, Wenjiang
    Wang, Xuebin
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 287 - 292
  • [28] Synthesis and evaluation of 4-(2-fluoro-4-[11C]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain
    Kumata, Katsushi
    Hatori, Akiko
    Yamasaki, Tomoteru
    Zhang, Yiding
    Mori, Wakana
    Fujinaga, Masayuki
    Xie, Lin
    Nengaki, Nobuki
    Zhang, Ming-Rong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (03) : 483 - 491
  • [29] Synthesis of 1-(2,4-dichlorophenyl)-4-cyano-5-(4[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide ([11C]JHU75528) and 1-(2bromophenyl)-4-cyano-5-(4-[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide ([11C]JHU75575) as potential radioligands for PET imaging of cerebral cannabinoid receptor
    Fan, Hong
    Ravert, Hayden T.
    Holt, Daniel P.
    Dannals, Robert F.
    Horti, Andrew G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (12): : 1021 - 1036
  • [30] Synthesis and evaluation of 1-(cyclopropylmethyl)-4-(4-[11C] methoxyphenyl)-piperidin-1-yl-2-oxo-1,2-dihydropyridine-3-carbonitrile([11C]CMDC) for PET imaging of metabotropic glutamate receptor 2 in the rat brain
    Ma, Yufei
    Kumata, Katsushi
    Yui, Joji
    Zhang, Yiding
    Yamasaki, Tomoteru
    Hatori, Akiko
    Fujinaga, Masayuki
    Nengaki, Nobuki
    Xie, Lin
    Wang, Hui
    Zhang, Ming-Rong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (03) : 1014 - 1021